Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00278434 · ClinicalTrials.gov registry record · Phase 1
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
A Phase 1 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00278434 is a Phase 1 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 12 participants.
The verdict
NCT00278434, a Phase 1 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
RATIONALE: Chemoprevention is the use of certain drugs to keep tumors from forming, growing, or coming back. Zoledronate may prevent the growth of cervical cancer by blocking blood flow to cervical intraepithelial neoplasia cells. The use of zoledronate may keep cancer from forming. PURPOSE: This randomized is studying how well zoledronate works in treating patients with cervical intraepithelial neoplasia 2/3 or 3.
Interventions
- DRUG Zoledronate
- OTHER Placebo (Saline)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2005-04 |
| Est. Completion | 2008-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00278434
The ClinicalTrials.gov registry entry for NCT00278434 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Zoledronate is the first listed.
NCT00278434 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00278434 about?
NCT00278434 is a clinical study titled "Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3". RATIONALE: Chemoprevention is the use of certain drugs to keep tumors from forming, growing, or coming back. Zoledronate may prevent the growth of cervical cancer by blocking blood flow to cervical intraepithelial neoplasia cells. The use of zoledronate may keep cancer from forming. PURPOSE: This r...
What is the current status of trial NCT00278434?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2005-04. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00278434?
The interventions under investigation include: Zoledronate (DRUG), Placebo (Saline) (OTHER).
Who is sponsoring clinical trial NCT00278434?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.